ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned-Reference-Cited by-同舟云学术

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

Published:2011-07-21 Issue:3 Volume:365 Page:203-212
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Viviani Simonetta,Zinzani Pier Luigi,Rambaldi Alessandro,Brusamolino Ercole,Levis Alessandro,Bonfante Valeria,Vitolo Umberto,Pulsoni Alessandro,Liberati Anna Marina,Specchia Giorgina,Valagussa Pinuccia,Rossi Andrea,Zaja Francesco,Pogliani Enrico M.,Pregno Patrizia,Gotti Manuel,Gallamini Andrea,Scalabrini Delia Rota,Bonadonna Gianni,Gianni Alessandro M.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1100340

Cited by 368 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin lymphoma: 2025 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-09-06

2. Analysis by TeloView® Technology Predicts the Response of Hodgkin’s Lymphoma to First-Line ABVD Therapy;Cancers;2024-08-10

3. Long‐term efficacy and safety of dose‐dense and dose‐intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15‐year follow‐up of the ABVD_DD‐DI phase II study;British Journal of Haematology;2024-08

4. Efficacy and safety of standard BEACOPP regimen versus ABVD regimen for treatment of advanced Hodgkin’s lymphoma;Journal of Cancer Research and Therapeutics;2024-08

5. Interim PET‐guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced‐stage classic Hodgkin lymphoma (JCOG1305);Cancer Science;2024-07-22